| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.066 | 0.1 |
| mRNA | Teniposide | CTRPv2 | pan-cancer | AAC | -0.069 | 0.1 |
| mRNA | AZD0530 | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.061 | 0.1 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | BRD-K09344309 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | lapatinib | GDSC1000 | pan-cancer | AAC | -0.08 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.06 | 0.1 |
| mRNA | Talazoparib | GDSC1000 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | Lisitinib | GDSC1000 | pan-cancer | AAC | 0.056 | 0.1 |